| 1. |
Fischer S, Rath T, Neurath MF. Inflammatory bowel diseases: Crohn’s disease and ulcerative colitis. Internist (Berl), 2018, 59(7): 681-693.
|
| 2. |
蔣麗琳, 肖南平, 楊興平, 等. CTGF mRNA在潰瘍性結腸炎組織中的表達及與病情和預后的關系. 國際消化病雜志, 2020, 40(2): 125-129.
|
| 3. |
Mohammed Vashist N, Samaan M, Mosli MH, et al. Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis. Cochrane Database Syst Rev, 2018, 1(1): 11450-11456.
|
| 4. |
劉麗, 柳云恩. 潰瘍性結腸炎患者血清miR-15表達水平與炎性反應狀態及預后的關系. 國際消化病雜志, 2020, 40(1): 41-46.
|
| 5. |
Yarani R, Mirza AH, Kaur S, et al. The emerging role of lncRNAs in inflammatory bowel disease. Exp Mol Med, 2018, 50(12): 1-14.
|
| 6. |
Qiao C, Yang L, Wan J, et al. Long noncoding RNA ANRIL contributes to the development of ulcerative colitis by miR-323b-5p/TLR4/MyD88/NF-κB pathway. Biochem Biophys Res Commun, 2019, 508(1): 217-224.
|
| 7. |
中華中醫藥學會. 潰瘍性結腸炎診療指南. 中國中醫藥現代遠程教育, 2011, 9(10): 126-128.
|
| 8. |
Jain S, Kedia S, Bopanna S, et al. Are Truelove and Witts criteria for diagnosing acute severe colitis relevant for the Indian population? A prospective study. Intest Res, 2018, 16(1): 69-74.
|
| 9. |
Landy J, Wahed M, Peake ST, et al. Oral tacrolimus as maintenance therapy for refractory ulcerative colitis–an analysis of outcomes in two London tertiary centres. J Crohns Colitis, 2013, 7(11): e516-e521.
|
| 10. |
Berends SE, Strik AS, L?wenberg M, et al. Clinical pharmacokinetic and pharmacodynamic considerations in the treatment of ulcerative colitis. Clin Pharmacokinet, 2019, 58(1): 15-37.
|
| 11. |
李晶瑩, 孫斐, 劉智娟. 受體相互作用蛋白激酶1在潰瘍性結腸炎患者組織中的表達及意義. 中國臨床藥理學雜志, 2020, 36(23): 3888-3891.
|
| 12. |
Gonzalez DO, Nwomeh BC. Complications in children with ulcerative colitis undergoing ileal pouch-anal anastomosis. Semin Pediatr Surg, 2017, 26(6): 384-390.
|
| 13. |
高成超, 程永波. 血小板異常與潰瘍性結腸炎關系的研究進展. 山東醫藥, 2020, 60(35): 109-111.
|
| 14. |
Lu C, Yang M, Luo F, et al. Prediction of lncRNA-disease associations based on inductive matrix completion. Bioinformatics, 2018, 34(19): 3357-3364.
|
| 15. |
賀林, 程龍, 周程繼, 等. 長鏈非編碼RNA結腸癌相關轉錄因子1與胃癌的研究進展. 中國普外基礎與臨床雜志, 2020, 27(9): 1180-1183.
|
| 16. |
Zacharopoulou E, Gazouli M, Tzouvala M, et al. The contribution of long non-coding RNAs in inflammatory bowel diseases. Dig Liver Dis, 2017, 49(10): 1067-1072.
|
| 17. |
孟云超, 牛桂軍. 炎癥性腸病中長鏈非編碼RNA的研究進展. 重慶醫學, 2019, 48(10): 1741-1744.
|
| 18. |
彭志浩, 李玉明. 長鏈非編碼RNA與結腸癌發生、發展關系的研究進展. 醫學研究雜志, 2020, 49(3): 9-11.
|
| 19. |
Chen SW, Wang PY, Liu YC, et al. Effect of long noncoding RNA H19 overexpression on intestinal barrier function and its potential role in the pathogenesis of ulcerative colitis. Inflamm Bowel Dis, 2016, 22(11): 2582-2592.
|
| 20. |
Zhou T, Wu L, Zong Z, et al. Long non-coding RNA mortal obligate RNA transcript inhibits the migration and invasion of colon cancer cells by inactivating transforming growth factor β1. Oncol Lett, 2020, 19(2): 1131-1136.
|
| 21. |
Sun Y, Zheng ZP, Li H, et al. ANRIL is associated with the survival rate of patients with colorectal cancer, and affects cell migration and invasion in vitro. Mol Med Rep, 2016, 14(2): 1714-1720.
|
| 22. |
Liu XW, Ma T, Liu W, et al. Sustained increase in angiopoietin-2, heparin-binding protein, and procalcitonin is associated with severe sepsis. J Crit Care, 2018, 45(1): 14-19.
|
| 23. |
張濤, 朱孝明, 楊俊玲. D-二聚體、PCT和CRP檢測在重癥胰腺炎中的臨床價值. 解放軍預防醫學雜志, 2020, 38(1): 17-18.
|
| 24. |
Wu HM, Wei J, Li J, et al. Serum procalcitonin as a potential early predictor of short-term outcomes in acute severe ulcerative colitis. Dig Dis Sci, 2019, 64(11): 3263-3273.
|
| 25. |
Lee MH, Tung-Chieh Chang J, Liao CT, et al. Interleukin 17 and peripheral IL-17-expressing T cells are negatively correlated with the overall survival of head and neck cancer patients. Oncotarget, 2018, 9(11): 9825-9837.
|
| 26. |
馬乾章, 李云, 丁原全. 白頭翁湯加味聯合美沙拉嗪緩釋片治療熱毒熾盛型潰瘍性結腸炎的臨床療效觀察. 海南醫學院學報, 2019, 25(12): 918-922.
|